Citi maintains a 'Buy' on Amylin Pharmaceuticals Inc (Nasdaq: AMLN), lowers price target from $27 to $25.

Citi analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE